Cargando…
Immunotherapy in Multiple Myeloma Using Cancer-Testis Antigens
CONTEXT: Multiple myeloma (MM) is a B-cell malignancy characterized by monoclonal expansion of abnormal plasma cells in the bone marrow. It accounts for 10% of hematological malignancies. Although patients respond to a wide range of anticancer modalities, relapse occurs in a significant number of th...
Autores principales: | Ghafouri-Fard, Soudeh, Seifi-Alan, Mahnaz, Shamsi, Roshanak, Esfandiary, Ali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shahid Beheshti University of Medical Sciences
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4667235/ https://www.ncbi.nlm.nih.gov/pubmed/26634107 http://dx.doi.org/10.17795/ijcp-3755 |
Ejemplares similares
-
Neuropilin-1 expression is associated with lymph node metastasis in breast cancer tissues
por: Seifi-Alan, Mahnaz, et al.
Publicado: (2018) -
Cancer-testis antigen SLLP1 represents a promising target for the immunotherapy of multiple myeloma
por: Yousef, Sara, et al.
Publicado: (2015) -
Urine exosome gene expression of cancer-testis antigens for prediction of bladder carcinoma
por: Yazarlou, Fatemeh, et al.
Publicado: (2018) -
Cancer testis antigen and immunotherapy
por: Krishnadas, Deepa Kolaseri, et al.
Publicado: (2013) -
Expression of testis-specific genes, TEX101 and ODF4, in chronic myeloid leukemia and evaluation of TEX101 immunogenicity
por: Ghafouri-Fard, Soudeh, et al.
Publicado: (2012)